SACHIN GUPTA M.D. NPI 1144343005

NPI Details

Sachin Gupta, M.D. is a hematology and oncology internal medicine in Fresno, CA with 25 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Sachin Gupta, M.D. NPI is 1144343005. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

7130 N MILLBROOK AVE
SUITE 100
FRESNO, CA
ZIP 93720
Phone: (559) 326-1238
Fax: (559) 326-1230

The NPI 1144343005 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, paclitaxel protein-bound particles, 1 mg (HCPCS:J9264)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, lanreotide, 1 mg (HCPCS:J1930)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
• Injection, atezolizumab, 10 mg (HCPCS:J9022)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Folic acid level, serum (HCPCS:82746)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Magnesium level (HCPCS:83735)
• Vitamin d-3 level (HCPCS:82306)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Unclassified drugs (HCPCS:J3490)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Electrophoresis, laboratory testing technique (HCPCS:82664)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Urinalysis, manual test (HCPCS:81002)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, clotting time (HCPCS:85610)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Declotting of central venous tube (HCPCS:36593)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Injection, metoclopramide hcl, up to 10 mg (HCPCS:J2765)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Testosterone (hormone) level, total (HCPCS:84403)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Ct scan of chest without contrast (HCPCS:71250)
• Ct scan of chest with contrast (HCPCS:71260)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Unclassified biologics (HCPCS:J3590)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• Phosphate level (HCPCS:84100)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)

The enumeration date for this NPI number is 4/7/2007 and was last updated on 7/26/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.